Table 2.
S.NO | Target | Material | Detection Methods | Linear Range | LOD | References |
---|---|---|---|---|---|---|
Electrochemical immunosensor | ||||||
1. | CA 15.3 | Ag-RGO/CysA-Au NPs | ChA | 15–125 U/mL | 15 U/mL | [51] |
2. | CA 125 | rGO/Thi/AuNPs | CV, DPV |
0.1~200 U/mL | 0.01 U/mL | [36] |
3. | Spike protein of SARS-CoV-2 | CNC-SPGE | DPV | 0.1 pg/mL to 500 ng/mL | 2.0 fg/mL | [52] |
4. | Human IFN-γ | PANI/G | EIS | 5–1000 pg/mL | 3.4 pg/mL | [53] |
5. | Glycoprotein | SiO2@Au/dsDNA/CeO2 | DPV | 1 pg/mL–1000 ng/mL | 0.87 pg/mL | [54] |
6. | Alpha-fetoprotein | Ni-Co MOF | DPV | 1–200 ng/mL | 0.3 ng/mL | [55] |
7. | Cardiac troponin I | MXene | EIS | 5–100 ng/mL | 0.58 ng/mL | [56] |
8. | 5-hydroxy-l-tryptophan | Graphene nanoribbons | SWV | 25–1000 μmol/L | 7.6 μmol/L | [57] |
Aptasensor | ||||||
9. | Carcinoembryonic antigen | NG-THI-AuNPs-PB-PEDOT | DPV | 0.01–500 ng/mL | 2 pg/mL | [58] |
10. | 17β-Estradiol | Amino redox graphene/thionine/streptavidin-modified gold nanoparticles/chitosan | DPV | 10 pg/mL to 100 ng/mL | 10 pg/mL | [59] |
11. | Kanamycin | Graphene | Potentiometry | 0.05–30 pM | 0.05 pM | [60] |
12. | Breast cancer cells (MCF-7) | Paper-based aptasensor and gold nanoparticles | CV, DPV and EIS | 20 to 1 × 106 cells mL−1 | 7 cells mL−1 | [61] |
13. | Programmed death-ligand 1 | Amino carbon nanotubes/methylene blue | CV, DPV |
10 pg/mL–2.5 ng/mL | 10 pg/mL | [62] |
14. | Oxytetracycline | Multiwall carbon nanotubes, gold nanoparticles, reduced graphene oxide and chitosan | CV, DPV and EIS |
1.00–540 nM | 10 nM | [63] |
15. | SARS-CoV-2 | Carbon nanofibers and gold nanoparticles | EIS | 0.01–64 nM | 7.0 pM | [64] |